Nurix Therapeutics (NRIX) Return on Sales [ROS] (2019 - 2026)
Nurix Therapeutics (NRIX) recorded Return on Sales [ROS] of 83.12% in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 1240.77 percentage points from -1157.65% a year earlier and up 1124.85 percentage points from the prior quarter.
Nurix Therapeutics (NRIX) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
On a TTM basis, Nurix Therapeutics' Return on Sales [ROS] came in at 41.27% as of Aug 31, 2026, up 360.58 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it was -340.16%, up 50.36 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of +24.50 percentage points (FY2020 to FY2025).
- Across earlier fiscal years, Return on Sales [ROS] came in at -390.52% in FY2024 (-189.11 pp), -201.41% in FY2023 (+274.59 pp), -476.01% in FY2022 (-79.75 pp) and -396.26% in FY2021 (-31.59 pp).
- The fiscal Q3 2026 figure is the highest quarterly Return on Sales [ROS] in data going back to fiscal Q3 2019.
- On a year-over-year basis, Return on Sales [ROS] rose in two of the last eight quarters, with an average year-over-year change of -205.39 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 1240.77 percentage points in fiscal Q3 2026, against a drop of 1138.78 percentage points in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -1041.73% (Q2 2026), -1479.45% (Q1 2026) and -612.03% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 83.12% |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 83.12% |
| May 31, 2026 | -1,041.73% |
| Feb 28, 2026 | -1,479.45% |
| Nov 30, 2025 | -612.03% |
| Aug 31, 2025 | -1,157.65% |
| May 31, 2025 | -109.68% |
| Feb 28, 2025 | -340.67% |
| Nov 30, 2024 | -486.73% |
| Aug 31, 2024 | -433.83% |
| May 31, 2024 | -401.42% |
| Feb 29, 2024 | -272.65% |
| Nov 30, 2023 | -299.06% |
| Aug 31, 2023 | -216.67% |
| May 31, 2023 | -87.25% |
| Feb 28, 2023 | -338.60% |
| Nov 30, 2022 | -717.82% |
| Aug 31, 2022 | -432.93% |
| May 31, 2022 | -399.89% |
| Feb 28, 2022 | -444.28% |
| Nov 30, 2021 | -513.16% |
Nurix Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();